Registered users can save articles to their personal articles list. Login here or sign up here

Pharma group Aspen lists on A2X

A2X’s combined market cap now stands at R2.2tr.

Aspen Pharmacare listed on alternative exchange A2X bourse on Monday, making it the fifth-largest company by market cap to list on the new bourse. The company will retain its primary listing on the JSE. Aspen has recently faced some challenges, and its share price has taken a knock with a continued sense of weakness in the company to date.

Read: Aspen: are the execs drinking their own Kool-Aid?

To speak about adding another big company to the exchange, Kevin Brady, the CEO of A2X speaks with Arabile Gumede. 

Get access to Moneyweb's financial intelligence and support quality journalism for only
R63/month or R630/year.
Sign up here, cancel at any time.

AUTHOR PROFILE

COMMENTS   0

To comment, you must be registered and logged in.

LOGIN HERE

Don't have an account?
Sign up for FREE

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR

LATEST PODCASTS

Podcasts

SHOP NEWSLETTERS TRENDING CPD HUB

Follow us:

Search Articles:Advanced Search
Click a Company:
server: 172.17.0.2